Astrin Biosciences
Astrin Biosciences is a startup headquartered in Saint Paul, United States, founded in 2020. It has raised at least $22.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory. Last updated .
Funding
Astrin Biosciences has raised at least $22.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
Related
- Innovation profile of Saint Paul
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Astrin Biosciences do?
Astrin Biosciences is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Astrin Biosciences raised?
At least $22.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Astrin Biosciences based?
Astrin Biosciences is headquartered in Saint Paul, United States.
When was Astrin Biosciences founded?
Astrin Biosciences was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.